Biological indicators of the in-utero environment and their association with birth weight for gestational age

Journal of Developmental Origins of Health and Disease

Volumn 2, Issue 5, 2011, Pages 280-290

  Talge, N M ^a   Holzman, C ^a   Senagore, P K ^b   Klebanoff, M ^c   Fisher, R ^a  

^a MICHIGAN STATE UNIVERSITY   (United States)

^b MICHIGAN STATE UNIVERSITY   (United States)

^c OHIO STATE UNIVERSITY   (United States)

Author keywords

birth weight; estriol; Key wordsalpha fetoproteins; placenta; pregnancy complications

Indexed keywords

EID: 84867387412     PISSN: 20401744     EISSN: 20401752     Source Type: Journal    
DOI: 10.1017/S2040174411000298     Document Type: Article

References (50)

1. Barker DJP. Fetal and Infant Origins of Adult Disease, 1992. BMJ Publishing Group: London.
2. Breslau N, Paneth N, Lucia VC, Paneth-Pollak R. Maternal smoking during pregnancy and offspring IQ. Int J Epidemiol. 2005; 34, 1047-1053. (Pubitemid 41535550)
3. Thompson C, Syddall H, Rodin I, Osmond C, Barker DJP. Birth weight and the risk of depressive disorder in late life. Br J Psychiatry. 2001; 179, 450-455. (Pubitemid 33097169)
4. Lahti J, Raikkonen K, Kajantie E, et al. Small body size at birth and behavioral symptoms of ADHD in children aged five to six years. J Child Psychol Psychiatry. 2006; 47, 1167-1174. (Pubitemid 44667857)
5. Devaskar SU, Thamotharan M. Metabolic programming in the pathogenesis of insulin resistance. Rev Endocr Metab Disord. 2007; 8, 105-113. (Pubitemid 47434650)
6. Broekman BFP, Chan YK, Chong YS, et al. The influence of birth size on intelligence in healthy children. Pediatrics. 2009; 123, e1011-e1016.
7. Pesonen AK, Raikkonen K, Kajantie E, et al. Fetal programming of temperamental negative affectivity among children born healthy at term. Dev Psychobiol. 2006; 48, 633-643. (Pubitemid 44935231)
8. Barker DJP, Osmond C, Forsén TJ, Kajantie E, Eriksson JG. Maternal and social origins of hypertension. Hypertension. 2007; 50, 565-571. (Pubitemid 47312245)
9. Nathanielsz PW. Animal models that elucidate basic principles of the developmental origins of adult diseases. ILAR J. 2006; 47, 73-82. (Pubitemid 43013514)
10. Nathanielsz PW, Poston L, Taylor PD. In utero exposure to maternal obesity and diabetes: animal models that identify and characterize implications for future health. Clin Perinatol. 2007; 34, 515-526, v. (Pubitemid 350193251)
11. Kajantie E, Phillips DI, Andersson S, et al. Size at birth, gestational age and cortisol secretion in adult life: foetal programming of both hyper-and hypocortisolism? Clin Endocrinol (Oxf). 2002; 57, 635-641. (Pubitemid 35316981)
12. Yogev Y, Visser GH. Obesity, gestational diabetes and pregnancy outcome. Semin Fetal Neonatal Med. 2009; 14, 77-84.
13. Scott A, Moar V, Ounsted M. The relative contributions of different maternal factors in small-for-gestational-age pregnancies. Eur J Obstet Gynecol Reprod Biol. 1981; 12, 157-165. (Pubitemid 11043008)
14. Kramer MS. Intrauterine growth and gestational duration determinants. Pediatrics. 1987; 80, 502-511. (Pubitemid 17151696)
15. Xiong X, Demianczuk NN, Saunders LD,Wang FL, Fraser WD. Impact of preeclampsia and gestational hypertension on birth weight by gestational age. Am J Epidemiol. 2002; 155, 203-209. (Pubitemid 34117298)
16. Bernstein PS, Divon MY. Etiologies of fetal growth restriction. Clin Obstet Gynecol. 1997; 40, 723-729. (Pubitemid 28135555)
17. Langer O. Fetal macrosomia: etiologic factors. Clin Obstet Gynecol. 2000; 43, 283-297. (Pubitemid 30450542)
18. Yaron Y, Cherry M, Kramer RL, et al. Second-trimester maternal serum marker screening: maternal serum alphafetoprotein, beta-human chorionic gonadotropin, estriol, and their various combinations as predictors of pregnancy outcome. Am J Obstet Gynecol. 1999; 181, 968-974. (Pubitemid 29503625)
19. Kowalczyk TD, Cabaniss ML, Cusmano L. Association of low unconjugated estriol in the second trimester and adverse pregnancy outcome. Obstet Gynecol. 1998; 91, 396-400. (Pubitemid 28119842)
20. Dugoff L, Hobbins JC, Malone FD, et al. Quad screen as a predictor of adverse pregnancy outcome. Obstet Gynecol. 2005; 106, 260-267. (Pubitemid 41023261)
21. Goodwin TM. A role for estriol in human labor, term and preterm. Am J Obstet Gynecol. 1999; 180, S208-S213. (Pubitemid 29072383)
22. Peck JD, Hulka BS, Savitz DA, et al. Accuracy of fetal growth indicators as surrogate measures of steroid hormone levels during pregnancy. Am J Epidemiol. 2003; 157, 258-266. (Pubitemid 36152440)
23. Salafia CM, Vintzileos AM, Silberman L, Bantham KF, Vogel CA. Placental pathology of idiopathic intrauterine growth retardation at term. Am J Perinat. 1992; 9, 179-184.
24. Salafia CM, Zhang J, Charles AK, et al. Placental characteristics and birthweight. Paediatr Perinat Epidemiol. 2008; 22, 229-239. (Pubitemid 351551207)
25. Barker DJP, Thornburg KL, Osmond C, Kajantie E, Eriksson JG. Beyond birthweight: the maternal and placental origins of chronic disease. J Dev Orig Health Dis. 2010; 1, 360-364.
26. Holzman C, Bullen B, Fisher R, Paneth N, Reuss L. Pregnancy outcomes and community health: the POUCH study of preterm delivery. Paediatr Perinat Ep. 2001; 15, 136-158. (Pubitemid 33719624)
27. Gabbe SG, Niebyl JR, Simpson JL. Obstetrics: Normal and Problem Pregnancies, 4th edn, 2002. Elsevier Science: Philadelphia, PA.
28. Levine RJ, Hauth JC, Curet LB, et al. Trial of calcium to prevent pre-eclampsia. New Eng J Med. 1997; 337, 69-77.
29. Zambrowski. NHBPEP report on high blood pressure in pregnancy: a summary for family physicians. Am Fam Physician. 2001; 64, 264.
30. Gifford RW, August PA, Cunningham G, et al. Report of the National High Blood Pressure Education Program Working Group on high blood pressure in pregnancy. Am J Obstet Gynecol. 2000; 183, S1-S22.
31. Gargano JW, Holzman CB, Senagore PK, et al. Polymorphisms in thrombophilia and renin-angiotensin system pathways, preterm delivery, and evidence of placental hemorrhage. Am J Obstet Gynecol. 2009; 201, 317, e311-319.
32. Kelly R, Holzman C, Senagore P, et al. Placental vascular pathology findings and pathways to preterm delivery. Am J Epidemiol. 2009; 170, 148-158.
33. Holzman C, Lin X, Senagore P, Chung H. Histologic chorioamnionitis and preterm delivery. Am J Epidemiol. 2007; 166, 786-794. (Pubitemid 47428908)
34. Kramer MS, Platt RW, Wen SW, et al. A new and improved population-based Canadian reference for birth weight for gestational age. Pediatrics. 2001; 108, E35-E41.
35. Salafia CM, Silberman C, Herrera N, Mahoney M. Placental pathology at term associated with elevated midtrimester maternal serum AFP concentration. Am J Obstet Gynecol. 1988; 158, 1064-1066.
36. Kaijser M, Granath F, Jacobsen G, Cnattingius S, Ekbom A. Maternal pregnancy estriol levels in relation to anamnestic and fetal anthropometric data. Epidemiology. 2000; 11, 315-319. (Pubitemid 30228201)
37. Ilagan JG, Stamilio DM, Ural SH, Macones GA, Odibo AO. Abnormal multiple marker screens are associated with adverse perinatal outcomes in cases of intrauterine growth restriction. Am J Obstet Gynecol. 2004; 191, 1465-1469. (Pubitemid 39421615)
38. Bradley LA, Canick JA, Palomaki GE, Haddow JE. Undetectable maternal serum unconjugated estriol levels in the second trimester: risk of perinatal complications associated with placental sulfatase deficiency. Am J Obstet Gynecol. 1997; 176, 531-535. (Pubitemid 27147156)
39. Kashork CD, Sutton VR, Fonda Allen JS, et al. Low or absent unconjugated estriol in pregnancy: an indicator for steroid sulfatase deficiency detectable by fluorescence in situ hybridization and biochemical analysis. Prenat Diagn. 2002; 22, 1028-1032. (Pubitemid 35407837)
40. Lagiou P, Samoli E, Lagiou A, Hsieh C, Adami H, Trichopoulos D. Maternal height, pregnancy estriol, and birth weight in reference to breast cancer risk in Boston and Shanghai. Int J Cancer. 2005; 117, 494-498. (Pubitemid 41429574)
41. Becroft DMO, Thompson JMD, Mitchell EA. The epidemiology of placental infarction at term. Placenta. 2002; 23, 343-351. (Pubitemid 41348528)
42. Baergen RN. Manual of Benirschke and Kaufmann's Pathology of the Human Placenta, 2005. Springer: New York.
43. Yudkin PL, Wood L, Redman CW. Risk of unexplained stillbirth at different gestational ages. Lancet. 1987; 1, 1192-1194. (Pubitemid 17071547)
44. Joseph KS. Incidence-based measures of birth, growth restriction, and death can free perinatal epidemiology from erroneous concepts of risk. J Clin Epidemiol. 2004; 57, 889-897. (Pubitemid 39422526)
45. Zhu MJ, Ford SP, Means WJ, Hess BW, Nathanielsz PW, Du M. Maternal nutrient restriction affects properties of skeletal muscle in offspring. J Physiol. 2006; 575, 241-250. (Pubitemid 44178141)
46. Gamborg M, Andersen PK, Baker JL, et al. Life course path analysis of birth weight, childhood growth, and adult systolic blood pressure. Am J Epidemiol. 2009; 169, 1167-1178.
47. Dahly DL, Adair LS, Bollen KA. A structural equation model of HTE developmental origins of blood pressure. Int J Epidemiol. 2008; 38, 538-548.
48. Smith GC, Wood AM, White IR, Pell JP, Hattie J. Birth weight and the risk of cardiovascular disease in the maternal grandparents. Am J Epidemiol. 2010; 171, 736-744.
49. Smith GC, Pell JP, Walsh D. Pregnancy complications and maternal risk of ischaemic heart disease: a retrospective cohort study of 129,290 births. Lancet. 2001; 357, 2002-2006. (Pubitemid 32592386)
50. Breslau N, Chilcoat H, DelDotto J, Adreski P, Brown G. Low birth weight and neurocognitive status at six years of age. Biol Psychiat. 1996; 40, 389-397. (Pubitemid 26301070)